The TGA said it first identified the potential association between GLP-1 drugs and NAION in 2024 when a study was published in the Journal of the American Medical Association (JAMA) Ophthalmology
As regards the different GLP-1 RA brands, Victoza was the most dispensed brand of GLP-1 RAs among incident patients in 2019, with Ozempic being the second most common, closely followed by Saxenda (Fig
Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, Tibaduiza-Arvalo LC, Forero-Crdenas S, Carrillo-Vaca L, Rojas-Rodrguez LC, Calderon-Ospina CA, Rodrguez-Quintana J (2025) GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives
Ozempic est un mdicament injectable destin aux adultes atteints de diabte de type 2 pour amliorer les niveaux de sucre dans le sang
The included studies varied in design, populations, drug regimens, treatment duration, and body-composition methods
Anderson CP, Reynolds CP